Author: Cyrus McAllister - Page 2

Whistleblower protections shield manufacturing workers who report safety defects, from toys to medical devices. Learn which laws apply, deadlines to meet, and how to avoid retaliation.

Clinical evidence shows generic drugs are just as safe and effective as brand-name drugs for most people. Learn when generics work, when to be cautious, and what to do if you notice a difference after switching.

Grapefruit can dangerously increase statin levels in your blood, raising the risk of muscle damage and kidney failure. Learn which statins are affected, how to stay safe, and what to do if you love grapefruit.

Cystic fibrosis is a genetic disease causing thick mucus in the lungs and organs. New CFTR modulator drugs like Trikafta have transformed survival rates, but access and cost remain major barriers for many.

Liver transplantation is the only cure for end-stage liver disease. Learn who qualifies, what happens during surgery, and the lifelong commitment to immunosuppression that follows.

Next-generation GLP-1 agents like retatrutide and orforglipron offer unprecedented weight loss but come with persistent GI side effects and unknown long-term risks. Learn what's new, what's risky, and what you need to know before starting.

African-made antiretroviral generics are transforming HIV treatment access, with the first WHO-prequalified African-produced TLD drug delivered in 2025. Local production cuts costs, strengthens supply chains, and empowers health sovereignty.

Otosclerosis is a common cause of hearing loss in adults under 50, caused by abnormal bone growth around the stapes. It leads to progressive conductive hearing loss, especially in low tones, but can be effectively treated with hearing aids or surgery.

ACE inhibitors and ARBs are the cornerstone of treatment for diabetic nephropathy, reducing proteinuria and slowing kidney damage. Maximal dosing is key-low doses offer little protection. Learn when to use them, when to avoid combinations, and how to handle creatinine changes.

State laws on generic drug substitution vary widely across the U.S., affecting cost, safety, and pharmacist workload. Learn how mandatory vs. permissive rules, patient consent, biologic restrictions, and liability protections differ by state-and what it means for you.